(Q35412114)

8 August 2017

title

Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis (English)

1 reference

8 August 2017

main subject

visceral leishmaniasis

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

David Launay

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Suman Gupta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Vanessa Yardley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Preeti Vishwakarma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Bhawna Sharma

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Denis Martin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Sunil K Puri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

English

0 references

publication date

10 November 2014

1 reference

Journal of Antimicrobial Chemotherapy

8 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

518-527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25389223%20AND%20SRC:MED&resulttype=core&format=json

Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Leishmaniasis impact and treatment access

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Drug targets and mechanisms of resistance in the anaerobic protozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Synthesis and structure-activity relationships of varied ether linker analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5h-imidazo[2,1-b][1,3]oxazine (PA-824).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Synthetic Nitroimidazoles: Biological Activities and Mutagenicity Relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Synthesis, structure-activity relationships, and biological studies of chromenochalcones as potential antileishmanial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Antileishmanial activity, uptake, and biodistribution of an amphotericin B and poly(α-Glutamic Acid) complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Recent advances in leishmaniasis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Leishmaniasis chemotherapy--challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422

Immunopathogenesis of infection with the visceralizing Leishmania species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU422